Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Medical Law Review|May 3, 2026
The promise of the EU's draft repurposing programmeGabriela Lenarczyk, Johnathon LiddicoatJournal of Law and the Biosciences|October 7, 2021
An empirical study of large, human biobanks: intellectual property policies and financial conditions for accessMatthew Jordan, Johnathon Liddicoat, Kathleen LiddellNature Biotechnology|April 8, 2015
Are the gene-patent storm clouds dissipating? A global snapshotJohnathon Liddicoat, Tess Whitton, Dianne NicolIIC; International Review of Industrial Property and Copyright Law|May 22, 2023
Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?Żaneta Zemła-Pacud, Gabriela LenarczykJournal of Law and the Biosciences|November 12, 2025
The future of AI regulation in drug development: a comparative analysisGabriela Lenarczyk, Timo Minssen, Nicholson Price, et al.Science Translational Medicine|June 26, 2024
New government drug repurposing programs: Opportunities and uncertaintiesJohnathon Liddicoat, Ashleigh Hamidzadeh, Kathleen Liddell, et al.European Journal of Human Genetics : EJHG|March 9, 2019
Continental drift? Do European clinical genetic testing laboratories have a patent problem?Johnathon Liddicoat, Kathleen Liddell, Arlie H McCarthy, et al.Pageof 1